Received May 8, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
Hyperaldosteronism, unspecified; Arteriosclerotic coronary artery disease/CAD; S/S ACS; Cardiac arrhythmia; Stable angina; Sinoatrial node dysfunction; Cardiac syncope; Proteinuria; Hypergammaglobulinemia, unspecified; Hyperproteinemia; Cognitive dysfunction; Essential hypertension/Hypertension; Mixed hyperlipidemia; Fatty liver; Precordial chest pain; Dyspnoea on exertion; Palpitation; Abdominal pain; Bilateral edema of lower extremity; Neurological dysfunction; TIA; Mini stroke; Pheochromocytoma; Myalgias; This spontaneous case was reported by a consumer and describes the occurrence of TRANSIENT ISCHAEMIC ATTACK (TIA), CEREBROVASCULAR ACCIDENT (Mini stroke), PHAEOCHROMOCYTOMA (Pheochromocytoma), HYPERALDOSTERONISM (Hyperaldosteronism, unspecified), ARTERIOSCLEROSIS CORONARY ARTERY (Arteriosclerotic coronary artery disease/CAD), ACUTE CORONARY SYNDROME (S/S ACS), ARRHYTHMIA (Cardiac arrhythmia), ANGINA PECTORIS (Stable angina), SINUS NODE DYSFUNCTION (Sinoatrial node dysfunction) and SYNCOPE (Cardiac syncope) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Co-suspect product included non-company product Tozinameran (Pfizer BioNTech COVID-19 vaccine) for an unknown indication. The patient's past medical history included Liver transplant. Concurrent medical conditions included Non-smoker (Never smoker). In June 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient received dose of Tozinameran (Pfizer BioNTech COVID-19 vaccine) (unknown route) 1 dosage form. In June 2021, the patient experienced PHAEOCHROMOCYTOMA (Pheochromocytoma) (seriousness criterion medically significant) and MYALGIA (Myalgias). On 24-Jun-2021, the patient experienced CEREBROVASCULAR ACCIDENT (Mini stroke) (seriousness criterion medically significant). On an unknown date, the patient experienced TRANSIENT ISCHAEMIC ATTACK (TIA) (seriousness criterion medically significant), HYPERALDOSTERONISM (Hyperaldosteronism, unspecified) (seriousness criterion medically significant), ARTERIOSCLEROSIS CORONARY ARTERY (Arteriosclerotic coronary artery disease/CAD) (seriousness criterion medically significant), ACUTE CORONARY SYNDROME (S/S ACS) (seriousness criterion medically significant), ARRHYTHMIA (Cardiac arrhythmia) (seriousness criterion medically significant), ANGINA PECTORIS (Stable angina) (seriousness criterion medically significant), SINUS NODE DYSFUNCTION (Sinoatrial node dysfunction) (seriousness criterion medically significant), SYNCOPE (Cardiac syncope) (seriousness criterion medically significant), PROTEINURIA (Proteinuria), HYPERGAMMAGLOBULINAEMIA (Hypergammaglobulinemia, unspecified), HYPERPROTEINAEMIA (Hyperproteinemia), COGNITIVE DISORDER (Cognitive dysfunction), ESSENTIAL HYPERTENSION (Essential hypertension/Hypertension), TYPE V HYPERLIPIDAEMIA (Mixed hyperlipidemia), HEPATIC STEATOSIS (Fatty liver), CHEST PAIN (Precordial chest pain), DYSPNOEA EXERTIONAL (Dyspnoea on exertion), PALPITATIONS (Palpitation), ABDOMINAL PAIN (Abdominal pain), OEDEMA PERIPHERAL (Bilateral edema of lower extremity) and NERVOUS SYSTEM DISORDER (Neurological dysfunction). At the time of the report, TRANSIENT ISCHAEMIC ATTACK (TIA), CEREBROVASCULAR ACCIDENT (Mini stroke), HYPERALDOSTERONISM (Hyperaldosteronism, unspecified), HYPERGAMMAGLOBULINAEMIA (Hypergammaglobulinemia, unspecified), HYPERPROTEINAEMIA (Hyperproteinemia) and COGNITIVE DISORDER (Cognitive dysfunction) had not resolved and PHAEOCHROMOCYTOMA (Pheochromocytoma), ARTERIOSCLEROSIS CORONARY ARTERY (Arteriosclerotic coronary artery disease/CAD), ACUTE CORONARY SYNDROME (S/S ACS), ARRHYTHMIA (Cardiac arrhythmia), ANGINA PECTORIS (Stable angina), SINUS NODE DYSFUNCTION (Sinoatrial node dysfunction), SYNCOPE (Cardiac syncope), PROTEINURIA (Proteinuria), ESSENTIAL HYPERTENSION (Essential hypertension/Hypertension), TYPE V HYPERLIPIDAEMIA (Mixed hyperlipidemia), HEPATIC STEATOSIS (Fatty liver), CHEST PAIN (Precordial chest pain), DYSPNOEA EXERTIONAL (Dyspnoea on exertion), PALPITATIONS (Palpitation), ABDOMINAL PAIN (Abdominal pain), OEDEMA PERIPHERAL (Bilateral edema of lower extremity), NERVOUS SYSTEM DISORDER (Neurological dysfunction) and MYALGIA (Myalgias) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Jun-2021, Blood pressure measurement: 148/88 (BP location: Right arm) and BP was not significantly elevated. On 24-Jun-2021, Body height: 1.727 metre (5'8). On 24-Jun-2021, Body mass index: 27.67 kilogram per square metre BMI. On 24-Jun-2021, Body surface area: 1.96 square metre BSA. On 24-Jun-2021, Body temperature: 36.8 degree Celsius 98.2, degree Fahrenheit (oral). On 24-Jun-2021, Electrocardiogram: EKG was changed from previous, but nearly 8 years have passed since last EKG so unclear as to when change occurred. On 24-Jun-2021, Heart rate: 61. On 24-Jun-2021, Oxygen saturation: 100 % SPO2. On 24-Jun-2021, Respiratory rate: 18. On 24-Jun-2021, Weight: 82.6 kilogram 182lb. On an unknown date, Blood albumin: Hypergammaglobulinemia. On an unknown date, Blood aldosterone: Reference Range: 0.9-28.9 30.0 Ratio (High), 42 nanogram per decilitre Adult Reference Ranges for Aldosterone: < or = 28 (High). Hyperaldosteronism and Reference Range: 0.25-5.82 1.4 ng/mL/h. On an unknown date, Blood catecholamines: 1008 picogram per millilitre Reference Range: SUP SUPINE: <632 UPRIGHT: <1046. On an unknown date, Blood cortisol: 22.3 microgram per decilitre High Reference Range: For 8 a.m. (7-9 a.m.) Specimen: 4.0-22.0 Reference Range: For 4 p.m. (3-5 p.m.) Specimen:3.0-17.0. On an unknown date, Blood creatinine (0.60-1.29 milligram per decilitre): 1.54 milligram per decilitre High and 411 milligram per decilitre (High) Creatinine random urine. On an unknown date, Blood glucose (65-99 milligram per decilitre): 146 milligram per decilitre High. On an unknown date, Blood test: The most recent blood test, 49% and recently many abnormalities. On an unknown date, Blood urea (7-25 milligram per decilitre): 14 milligram per decilitre Urea nitrogen (BUN). On an unknown date, Catecholamines urine: 37 picogram per millilitre Reference Range: SUPINE: <16 UPRIGHT: <27 (High). On an unknown date, Globulin: Hypergammaglobulinemia. On an unknown date, Glomerular filtration rate: Reference Range: > or = 60 56 mL/min/1.73m2 (Low). On an unknown date, Norepinephrine: 918 picogram per millilitre Reference Range: SUPINE: 149-564 UPRIGHT: 199-937. On an unknown date, Protein total: Blood test indicated high level of proteins in blood and diagnosed with proteinuria. Hyperproteinaemia. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. It was reported that the patient had no known allergies. It was reported that the patient was a victim of Pfizer and Moderna vaccine. The patient had been diagnosed with heart defects, myocardial, TIA and continuously, ongoing medical cover ups by many physicians. On 23-Jun-2021, as reported health was declining and was dealing with ongoing neurological and cognitive dysfunction, the same doctor pressured to the patient by joining with two other clinicians. They had no good intentions for patient's safety for knowing that blood test results, the vaccine to a mini stroke on 24-Jun-2021. The ER Physician at Hospital only reported minimal symptoms to go against a Transient ischemic attack and heart defects. The patient was wrongfully cleared to go back to work after reported many symptoms of mini stroke. Since it was mandated for Employees to take the Moderna vaccine that nearly killed the patient on 24-Jun-2021 and cleared for work in condition. For years blood test indicated high level of proteins in blood and was diagnosed with proteinuria, myocardial, and many heart defects. On 24-Jun-2021, the patient presented in emergency department of the Hospital with myalgias after COVID vaccine. Nevertheless, did not appear to be ischemic, and resolution of symptoms with exertion yesterday (23-Jun-2021) also suggested against ischemia. As per the chart review, he was being worked up for pheochromocytoma, though BP right now was not significantly elevated (patient stated he had not taken his BP medicines yet today). Counselled to follow up with primary care doctor and took Tylenol PRN. The patient was discharged from the hospital on the same day (24-Jun-2021). The patient had received the treatment medications, Gabapentin Enacarbil, ER 300mg, tablet CR, 1 capsule, by mouth at night, Meloxicam (Mobic) 15 mg tablet, 1 tablet by mouth, Pantoprazole (Protonix) 40 mg 1 tablet by mouth before dinner every day, Rimegepant Sulfate (Nurtec) 75 mg tablet, dispersible, 1 tablet by mouth daily as needed, Magnesium Glycinate 665 mg, orally, Spironolactone 25mg, 1 tablet orally, Vitamin B12 1000MCG, 1 tablet orally once a day, Tadalafil 5mg, 1 tablet as needed orally once a day, Amlodipine Besy-Benazepril HCL 10-40MG, orally. Stable angina and CAD were discussed; signs and symptoms (s/s) of ACS and an action plan were reviewed. LDL goal of 70 was continued. Recurrent unexplained signs and symptoms of cardiac arrhythmia were noted, and monitoring was given due to their infrequency but high suspicion for arrhythmia. The remainder of medications was continued until further evaluation was completed. Approximately 30 minutes of preventative counselling was performed. This included review of the concepts of caloric balance and the use of counting or similar methods, ensuring intake was balanced with expenditure using hour recall. Dietary options were discussed, including recommended protein and fat intake, and various options were presented, including low fat/low carbohydrate diets, all of which were appropriate for the patient. Recommended options were discussed as well as dietary fibre intake. Specifics to gastric treatment and prevention through diet were discussed.; Reporter's Comments: The benefit-risk relationship of product is not affected by this report.
Non-smoker (Never smoker)
Medical History/Concurrent Conditions: Liver transplant
Test Name: Albumin; Result Unstructured Data: Hypergammaglobulinemia; Test Name: Aldo/Pra/Ratio; Result Unstructured Data: Reference Range: 0.9-28.9 30.0 Ratio (High); Test Name: Aldosterone (LC/MS/MS); Result Unstructured Data: Test Result:42 ng/dL;Adult Reference Ranges for Aldosterone: < or = 28 (High). Hyperaldosteronism; Test Name: Plasma Renin Activity (LC/MS/MS); Result Unstructured Data: Reference Range: 0.25-5.82 1.4 ng/mL/h; Test Name: TOTAL CATECHOLAMINES; Result Unstructured Data: Test Result:1008 pg/mL;Reference Range: SUP SUPINE: <632 UPRIGHT: <1046; Test Name: Cortisol Total; Result Unstructured Data: Test Result:22.3 ug/dL;High Reference Range: For 8 a.m. (7-9 a.m.) Specimen: 4.0-22.0 Reference Range: For 4 p.m. (3-5 p.m.) Specimen:3.0-17.0; Test Name: Creatinine; Test Result: 1.54 mg/dL; Test Name: Creatinine random urine; Test Result: 411 mg/dL; Test Name: Glucose; Test Result: 146 mg/dL; Test Date: 20210624; Test Name: Blood pressure; Result Unstructured Data: 148/88 (BP location: Right arm); Test Date: 20210624; Test Name: BP; Result Unstructured Data: BP was not significantly elevated; Test Name: blood test; Result Unstructured Data: The most recent blood test, 49% and recently many abnormalities; Test Name: Urea nitrogen (BUN); Test Result: 14 mg/dL; Test Date: 20210624; Test Name: Height; Result Unstructured Data: Test Result:1.727 m;(5'8); Test Date: 20210624; Test Name: BMI; Result Unstructured Data: Test Result:27.67 kg/m2;BMI; Test Date: 20210624; Test Name: BSA; Result Unstructured Data: Test Result:1.96 m2;BSA; Test Date: 20210624; Test Name: Temperature; Result Unstructured Data: Test Result:36.8 Cel;98.2, degree Fahrenheit (oral); Test Name: Dopamine; Result Unstructured Data: Test Result:37 pg/mL;Reference Range: SUPINE: <16 UPRIGHT: <27 (High); Test Date: 20210624; Test Name: EKG; Result Unstructured Data: EKG was changed from previous, but nearly 8 years have passed since last EKG so unclear as to when change occurred; Test Name: Globulin; Result Unstructured Data: Hypergammaglobulinemia; Test Name: EGFR; Result Unstructured Data: Reference Range: > or = 60 56 mL/min/1.73m2 (Low); Test Date: 20210624; Test Name: Pulse rate; Result Unstructured Data: 61; Test Name: Norepinephrine; Result Unstructured Data: Test Result:918 pg/mL;Reference Range: SUPINE: 149-564 UPRIGHT: 199-937; Test Date: 20210624; Test Name: SPO2; Test Result: 100 %; Test Name: Proteins; Result Unstructured Data: Blood test indicated high level of proteins in blood and diagnosed with proteinuria. Hyperproteinaemia; Test Date: 20210624; Test Name: Respiratory rate; Result Unstructured Data: 18; Test Date: 20210624; Test Name: Weight; Test Result: 82.6 kg